TGFB1 and melanoma: Collectively, our analyses suggest an overall dysregulated cytokine-expressing B cell compartment in melanoma patient circulation, which appears to favor the induction of regulatory B cell (TGF-β+ and PD-L1+) subpopulations, alongside a collapse in pro-inflammatory (IFN-γ+ and TNF-α+) B cell subsets.